Poster Additional Sessions track
Poster Session 3 - Expanding Patient-Centric Innovation: Inclusive Approaches in Clinical Research and Beyond
Thu, Mar 20, 2025 · 11:50 AM–12:50 PM CET Innovation Hub (in Exhibition Hall), Congress Center Basel
About this session
This session highlights inclusive and patient-centric strategies shaping the future of clinical research and healthcare innovation.
Through rapid poster presentations, explore how diverse perspectives and innovative methodologies are driving impactful outcomes, including:
- Solving the Dilemma of Treatment Choice During Motherhood in Multiple Sclerosis: The Ocrelizumab Example
- Bridging Ages: Fusing Historical Adult Data with Real-World Evidence to Optimize Pediatric Trials
- Simultaneous National Scientific Advice “SNSA” Applicable to a Rare Disease Clinical Trial
- External Control Arm Studies in Marketing Authorisation Applications Submitted to the European Medicines Agency: A Review of Study Design Features and Methods
The session will conclude with a dynamic Q&A, providing an opportunity for attendees to interact with presenters and discuss how inclusive, patient-centric approaches can redefine innovation in clinical research and beyond.
Programme:
- 1. Solving the dilemma of treatment choice during motherhood in multiple sclerosis: the ocrelizumab example — Noemi Pasquarelli
- 4. Analysis of the Digital Transformation in the distribution of Risk Management Plan (RMP) Educational Materials (EMs) — Luvanka Hanxhari
- 2. Simultaneous National scientific advice “SNSA” applicable to a rare disease clinical trial — Hayet Bensikaddour
- 3. External Control Arm Studies in Marketing Authorisation Applications Submitted to the European Medicines Agency: A Review of Study Design Features and Methods — Xabier García De Albéniz
Speakers
-
Senior Manager AR&RM – RMP · Novartis
Speaker
-
Global Medical Lead Women's Health in Multiple Sclerosis · F. Hoffmann-La Roche AG
Speaker
